SoCalBio Mast
SoCalBio Weekly Update
Past Weekly Updates

Group Purchasing

 
 
 Utilize Iron Mountain for Document Management, Storage and Shredding
 
SoCalBio's Group Purchasing Committee is pleased to announce that Iron Mountain was selected to provide member companies with document management, storage and shredding services at significant discounts. To learn more and sign up, contact Jared Jerotz, Sales, Data Protection, Iron Mountain at jared.jerotz@ironmountain.com
(must be a SoCalBio member company or organization)
 __________________
 
 
Utilize AT Conference to Cut the Cost of Your Phone and Web Conferencing
 
SoCalBio's Group Purchasing Committee is pleased to announce that AT Conference was selected to provide member companies with phone and web conferencing services at significant discounts. Click to see benefits and enroll (must be a SoCalBio member company or organization)
 
Great Savings - SoCalBio Special Rate of 5¢/minute
Join SoCalBio
 
Join well-known entrepreneur Alfred Mann and other SoCalBio leaders to promote the biotech and device industries in the Greater Los Angeles Metro Area for job creation and overall economic growth.
Become a Member
Make a Donatation to Support the SoCalBio Weekly Update
Looking for Experts to Help You Craft PR, Communicaton and Branding Strategies?
 
Enhance your Career
LIFE SCIENCE
ENTREPRENEUR'S
BUSINESS LAW
PRIMER
 
June 27, 2009
Thomas Jefferson School of Law, San Diego
Recommended Events  
 
 
More Information
-------------------------------------

Register Now

Forward to a Friend

June 15, 2009
Thanks to Lead SoCalBio Sponsor
  

Coming This Fall

New SoCalBio Members
Biomedical Strategies (La Jolla)
Company offers reimbursement and regulatory compliance services ... Learn more 

City of Murrieta (Riverside County)

 
The City of Murrieta is attracting upscale retail centers and quality hotels, as well as research & development and medical technology firms and first-rate healthcare facilities. For more information, contact Murrietta's Economic Development Director Bruce Coleman at bcoleman@murrieta.org or call (951) 461-6021
 
Nesher Technologies (Los Angeles)
 
Nesher is using nanobiotech for innovative medical diagnostics and cutting edge biomedical research.
 
 
 
Company provides regulatory consulting services for medical device, diagnostic and pharmaceutical firms. For more information, contact Robyn Scopis at robyn@regulatoryspecialists.com or call 949-422-3853.
 
TherOzone LLC (Santa Monica)
 
Company manufactures aqueous ozone unit for use by dentists ... Learn more 
 
USC Stevens Institute (Los Angeles)
USC Stevens Institute for Innovation is a university-wide resource for USC innovators in the office of the Provost. Designed to harness and advance the creative thinking and breakthrough research at USC for societal impact, beyond traditional academic means... Learn more

SoCalBio FDA Audit Workshop

Thank all the participants in the SoCalBio Workshop on FDA Audit and California Inspection Preparedness. See photo slide show and access presentations at: 
http://www.socalbio.org/regulatory/2009_Regulatory_Workshop.htm

RSVP Now for SoCalBio Events

  • June 19, 11 to 2
    • SoCalBio Luncheon and Roundtable Discussion for Regenerative Medicine Company Executives (By Invitation Only)
  • June 25, 7:00 - 9:30 am
    • SoCalBio Networking Forum (UCI University Club in Irvine): Contract Manufacturing Benchmarks and Best Practices
    • Speakers:
      • Richard Henson, President & CEO, Source Scientific (Irvine)
      • Barry Kazemi-President and CEO, Life Sci Outsourcing (Brea)
      • Pankaj Singhal, Ph.D., COO, Osmetech Molecular Diagnostics (Pasadena)
  • September 17, 7:00 am - 7:00 pm

From the Lab Bench

Caltech Develops a Mechanical Nanozipper That Senses Individual Photons

Scientists at Caltech have created an optomechanical nanodevice capable of detecting single photons passing through it. Because of this extreme sensitivity in a tiny package, the technology may find itself as a primary component in future imaging or diagnostic modalities.... Read more

Clinical Development

MannKind of Valencia, Calif. Unveils Next-Generation Inhalation System
 
MannKind Corporation announced today that it has begun clinical development of a next-generation inhalation system to optimize the delivery of drug powders based on the proprietary Technosphere technology platform. The inhalation system is as small as a whistle and designed to be easy-to-use, discreet and patient-friendly when used with therapies such as the investigational ultra rapid acting insulin AFRESA (insulin human [rDNA origin]) Inhalation Powder. The delivery system technology can also be used with other therapeutic proteins... Read more
 
ISTA Pharmaceuticals of Irvine, Calif. Announces Positive Results for Phase 2 Study of Low-Dose Bromfenac in Dry Eye Disease
 
"The strong clinical results from this proof-of-concept study further support our belief that a modified, low-dose formulation of bromfenac has the potential ability to effectively and conveniently treat signs and symptoms of dry eye disease and provide fast and sustainable relief for patients. Bromfenac's strong safety profile should support long-term treatment, which would be necessitated due to the chronic inflammatory nature of dry eye disease," stated Vicente Anido, Jr., Ph.D., President and Chief Executive Officer of ISTA Pharmaceuticals ... Read more

Stock Performance

MannKind Corporation's Shares Rise on Inhalable Insulin Outlook
 
 
Shares of MannKind Corp. (Valencia, Calif.) surged to a new 52-week peak last week after the company reported positive study data for its inhalable insulin candidate Afresa and said it started developing a new inhalable medication system. The Food and Drug Administration is reviewing the company's marketing application for Afresa... Read more

FDA Clearances

STAAR Surgical of Monrovia, Calif. Gets FDA Clearance for Eye Surgical Tool 
 
The FDA has approved STAAR's Epiphany Injector System, a single-use device that lets surgeons implant lenses into cataract patients' eyes. The company plans to start the first shipments of the product next month and fully launch it in August... Read more

Marketing

Abraxis Bioscience of Los Angeles, Calif. Launches ABRAXANE in China for Women with Metastatic Breast Cancer
 
"With the launch of ABRAXANE, Chinese women living with advanced breast cancer now have an important new treatment option. We look forward to working with Chinese healthcare professionals to bring ABRAXANE to patients in need," said Mr. Jonathan Zhu, General Manager of Abraxis BioScience China..... Read more

About SoCalBio

SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio 
Editor: Ahmed A. Enany
Southern California Biomedical Council (SoCalBio)